| Q47229964 | A High-fat, High-sugar 'Western' Diet Alters Dorsal Striatal Glutamate, Opioid, and Dopamine Transmission in Mice. |
| Q30485219 | A cAMP pathway underlying reward prediction in associative learning |
| Q36168175 | A comparison of striatal-dependent behaviors in wild-type and hemizygous Drd1a and Drd2 BAC transgenic mice |
| Q57296786 | A competitive model for striatal action selection |
| Q36940413 | A molecular switch for induction of long-term depression of corticostriatal transmission |
| Q34629593 | A neurocomputational account of catalepsy sensitization induced by D2 receptor blockade in rats: context dependency, extinction, and renewal |
| Q39502291 | A role for dopamine-mediated learning in the pathophysiology and treatment of Parkinson's disease. |
| Q48810494 | A simple method for characterizing passive and active neuronal properties: application to striatal neurons |
| Q27324171 | A53T-alpha-synuclein overexpression impairs dopamine signaling and striatal synaptic plasticity in old mice |
| Q37581600 | Acute and chronic effects of ethanol on learning-related synaptic plasticity. |
| Q36978473 | Acute ethanol suppresses glutamatergic neurotransmission through endocannabinoids in hippocampal neurons |
| Q28541409 | Adaptive gene regulation in the Striatum of RGS9-deficient mice |
| Q35056410 | Adenosine A(2A) Receptors and A(2A) Receptor Heteromers as Key Players in Striatal Function |
| Q35607243 | Adenosine A2a receptor antagonists attenuate striatal adaptations following dopamine depletion. |
| Q28286488 | Adenosine-cannabinoid receptor interactions. Implications for striatal function |
| Q42668061 | Adenylyl cyclase type 5 contributes to corticostriatal plasticity and striatum-dependent learning |
| Q38123275 | Advances in the pharmacological treatment of Parkinson's disease: targeting neurotransmitter systems |
| Q24657764 | Age-dependent alterations of corticostriatal activity in the YAC128 mouse model of Huntington disease |
| Q37161459 | Alterations in corticostriatal synaptic plasticity in mice overexpressing human alpha-synuclein |
| Q47555397 | Alterations in mGlu5 receptor expression and function in the striatum in a rat depression model. |
| Q35055022 | Altered Balance of Activity in the Striatal Direct and Indirect Pathways in Mouse Models of Huntington's Disease |
| Q60934814 | Altered Synaptic Vesicle Release and Ca Influx at Single Presynaptic Terminals of Cortical Neurons in a Knock-in Mouse Model of Huntington's Disease |
| Q35078309 | Altered hippocampal synaptic physiology in aged parkin-deficient mice |
| Q35039492 | An Improved BAC Transgenic Fluorescent Reporter Line for Sensitive and Specific Identification of Striatonigral Medium Spiny Neurons |
| Q28748890 | Anatomy of a songbird basal ganglia circuit essential for vocal learning and plasticity |
| Q36248857 | Anti-dyskinetic effects of cannabinoids in a rat model of Parkinson's disease: role of CB(1) and TRPV1 receptors. |
| Q42520592 | Apomorphine-induced modulation of neural activities in the ventrolateral striatum of rats |
| Q64782437 | Are we listening to everything the PARK genes are telling us? |
| Q45185178 | Association study of cannabinoid receptor 1 (CNR1) gene in tardive dyskinesia |
| Q93123575 | Axonal degeneration in Parkinson's disease - Basal ganglia circuitry and D2 receptor availability |
| Q30423739 | Behavioral abnormalities and circuit defects in the basal ganglia of a mouse model of 16p11.2 deletion syndrome |
| Q92914169 | Behavioral, circuitry, and molecular aberrations by region-specific deficiency of the high-risk autism gene Cul3 |
| Q50055065 | Bidirectional and long-lasting control of alcohol-seeking behavior by corticostriatal LTP and LTD. |
| Q91959308 | Biological bases for a possible effect of cannabidiol in Parkinson's disease |
| Q92572721 | Biology and Bias in Cell Type-Specific RNAseq of Nucleus Accumbens Medium Spiny Neurons |
| Q36759329 | Brain 2-Arachidonoylglycerol Levels Are Dramatically and Rapidly Increased Under Acute Ischemia-Injury Which Is Prevented by Microwave Irradiation |
| Q36797226 | CaMKII regulates diacylglycerol lipase-α and striatal endocannabinoid signaling |
| Q42493834 | Calcium dynamics predict direction of synaptic plasticity in striatal spiny projection neurons |
| Q91046020 | Cannabinoid CB1 receptors in the amygdalar cholecystokinin glutamatergic afferents to nucleus accumbens modulate depressive-like behavior |
| Q37734568 | Cannabinoid-dopamine interaction in the pathophysiology and treatment of CNS disorders. |
| Q38522769 | Cannabinoid-dopamine interactions in the physiology and physiopathology of the basal ganglia |
| Q40701861 | Cannabinoids for the Treatment of Movement Disorders. |
| Q42258332 | Cannabinoids in Parkinson's Disease |
| Q24633884 | Cannabinoids in health and disease |
| Q34699888 | Cannabis, the mind and society: the hash realities |
| Q30650489 | Cell type-specific plasticity of striatal projection neurons in parkinsonism and L-DOPA-induced dyskinesia |
| Q34183765 | Cell type-specific synaptic encoding of ethanol exposure in the nucleus accumbens shell |
| Q90140618 | Cell-Autonomous and Non-cell-Autonomous Pathogenic Mechanisms in Huntington's Disease: Insights from In Vitro and In Vivo Models |
| Q33711360 | Cellular mechanisms underlying burst firing in substantia nigra dopamine neurons. |
| Q38212230 | Cerebellar influence on motor cortex plasticity: behavioral implications for Parkinson's disease |
| Q38809530 | Chronic Nicotine Alters Corticostriatal Plasticity in the Striatopallidal Pathway Mediated By NR2B-Containing Silent Synapses |
| Q36889608 | Chronic Nicotine Mitigates Aberrant Inhibitory Motor Learning Induced by Motor Experience under Dopamine Deficiency |
| Q34358086 | Chronic THC intake modifies fundamental cerebellar functions |
| Q42481102 | Circuit-specific signaling in astrocyte-neuron networks in basal ganglia pathways. |
| Q38598509 | Clinical Endocannabinoid Deficiency Reconsidered: Current Research Supports the Theory in Migraine, Fibromyalgia, Irritable Bowel, and Other Treatment-Resistant Syndromes |
| Q40742869 | Cocaine Experience Enhances Thalamo-Accumbens N-Methyl-D-Aspartate Receptor Function. |
| Q47799371 | Cocaine Withdrawal Impairs mGluR5-Dependent Long-Term Depression in Nucleus Accumbens Shell Neurons of Both Direct and Indirect Pathways |
| Q36927168 | Cocaine-induced adaptations in D1 and D2 accumbens projection neurons (a dichotomy not necessarily synonymous with direct and indirect pathways). |
| Q48130770 | Combined activation of L-type Ca2+ channels and synaptic transmission is sufficient to induce striatal long-term depression. |
| Q30495714 | Competitive regulation of synaptic Ca2+ influx by D2 dopamine and A2A adenosine receptors |
| Q41169632 | Computing reward-prediction error: an integrated account of cortical timing and basal-ganglia pathways for appetitive and aversive learning |
| Q92886078 | Control of glutamate release by complexes of adenosine and cannabinoid receptors |
| Q42441040 | Convergence of cortical and thalamic input to direct and indirect pathway medium spiny neurons in the striatum |
| Q33756951 | Convergent evidence for abnormal striatal synaptic plasticity in dystonia |
| Q36445234 | Convergent mechanisms in etiologically-diverse dystonias |
| Q42479388 | Cortical and thalamic innervation of direct and indirect pathway medium-sized spiny neurons in mouse striatum. |
| Q24648260 | Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice. |
| Q42551042 | Corticostriatal and thalamostriatal synapses have distinctive properties |
| Q34315364 | Corticostriatal projection neurons – dichotomous types and dichotomous functions |
| Q45306738 | Corticostriatal synaptic function in mouse models of Huntington's disease: early effects of huntingtin repeat length and protein load |
| Q48093702 | Current Understanding of PDE10A in the Modulation of Basal Ganglia Circuitry |
| Q33575226 | Cyclic AMP and afferent activity govern bidirectional synaptic plasticity in striatopallidal neurons |
| Q46095429 | D2R striatopallidal neurons inhibit both locomotor and drug reward processes |
| Q43073344 | Decreased striatal dopamine release underlies increased expression of long-term synaptic potentiation at corticostriatal synapses 24 h after 3-nitropropionic-acid-induced chemical hypoxia |
| Q64251973 | Delayed Spine Pruning of Direct Pathway Spiny Projection Neurons in a Mouse Model of Parkinson's Disease |
| Q42178082 | Delta9-tetrahydrocannabinol (THC) and AM 404 protect against cerebral ischaemia in gerbils through a mechanism involving cannabinoid and opioid receptors |
| Q37129354 | Dendritic excitability and synaptic plasticity |
| Q41904397 | Development of a unilaterally-lesioned 6-OHDA mouse model of Parkinson's disease |
| Q43287350 | Developmental alterations of DHPG-induced long-term depression of corticostriatal synaptic transmission: switch from NMDA receptor-dependent towards CB1 receptor-dependent plasticity |
| Q34007247 | Developmental regulation and neuroprotective effects of striatal tonic GABAA currents |
| Q35607269 | Dichotomous anatomical properties of adult striatal medium spiny neurons |
| Q30493521 | Dichotomous dopaminergic control of striatal synaptic plasticity |
| Q33944484 | Different corticostriatal integration in spiny projection neurons from direct and indirect pathways |
| Q36122543 | Differential CaMKII regulation by voltage-gated calcium channels in the striatum |
| Q53446566 | Differential Synaptic Remodeling by Dopamine in Direct and Indirect Striatal Projection Neurons in Pitx3-/- Mice, a Genetic Model of Parkinson's Disease. |
| Q48340405 | Differential cortical activation of the striatal direct and indirect pathway cells: reconciling the anatomical and optogenetic results by using a computational method |
| Q35922870 | Differential degradation of motor deficits during gradual dopamine depletion with 6-hydroxydopamine in mice. |
| Q34764514 | Differential electrophysiological changes in striatal output neurons in Huntington's disease. |
| Q44463501 | Differential electrophysiological properties of dopamine D1 and D2 receptor-containing striatal medium-sized spiny neurons |
| Q37185190 | Differential striatal spine pathology in Parkinson's disease and cocaine addiction: a key role of dopamine? |
| Q46782245 | Differential tonic GABA conductances in striatal medium spiny neurons |
| Q38234309 | Direct and indirect pathways of basal ganglia: a critical reappraisal |
| Q42734818 | Dissecting the contribution of individual receptor subunits to the enhancement of N-methyl-d-aspartate currents by dopamine D1 receptor activation in striatum |
| Q41220847 | Distinct Functions of the Primate Putamen Direct and Indirect Pathways in Adaptive Outcome-Based Action Selection |
| Q42852538 | Distinct levels of dopamine denervation differentially alter striatal synaptic plasticity and NMDA receptor subunit composition. |
| Q33720464 | Distinct roles of GABAergic interneurons in the regulation of striatal output pathways |
| Q38593117 | Distribution of the Endocannabinoid System in the Central Nervous System |
| Q41899842 | Dopamine D2 receptor dysfunction is rescued by adenosine A2A receptor antagonism in a model of DYT1 dystonia. |
| Q34780457 | Dopamine D2 receptor overexpression alters behavior and physiology in Drd2-EGFP mice |
| Q37629163 | Dopamine and synaptic plasticity in dorsal striatal circuits controlling action selection |
| Q42579414 | Dopamine depletion induces distinct compensatory gene expression changes in DARPP-32 signal transduction cascades of striatonigral and striatopallidal neurons |
| Q24300992 | Dopamine dysregulation in a mouse model of paroxysmal nonkinesigenic dyskinesia |
| Q38121068 | Dopamine imbalance in Huntington's disease: a mechanism for the lack of behavioral flexibility |
| Q42444141 | Dopamine-dependent long-term depression at subthalamo-nigral synapses is lost in experimental parkinsonism |
| Q48114419 | Dopamine-dependent long-term depression is expressed in striatal spiny neurons of both direct and indirect pathways: implications for Parkinson's disease. |
| Q57295457 | Dopamine-endocannabinoid interactions mediate spike-timing-dependent potentiation in the striatum |
| Q34726418 | Dopamine-mediated learning and switching in cortico-striatal circuit explain behavioral changes in reinforcement learning |
| Q28972550 | Dopaminergic augmentation of delta-9-tetrahydrocannabinol (THC) discrimination: possible involvement of D2-induced formation of anandamide |
| Q30475711 | Dopaminergic dysfunction in schizophrenia: salience attribution revisited. |
| Q34001324 | Dopaminergic modulation of endocannabinoid-mediated plasticity at GABAergic synapses in the prefrontal cortex |
| Q92773981 | Dopaminergic modulation of striatal function and Parkinson's disease |
| Q38233462 | Dopaminergic modulation of striatal networks in health and Parkinson's disease |
| Q26862387 | Dopaminergic modulation of striatal neurons, circuits, and assemblies |
| Q35282100 | Dopaminergic modulation of synaptic transmission in cortex and striatum |
| Q36744457 | Dopaminergic signaling in dendritic spines |
| Q35044956 | Dorsal striatal D2-like receptor availability covaries with sensitivity to positive reinforcement during discrimination learning |
| Q42525723 | Drd1a-tdTomato BAC transgenic mice for simultaneous visualization of medium spiny neurons in the direct and indirect pathways of the basal ganglia. |
| Q34166000 | Drug-evoked synaptic plasticity in addiction: from molecular changes to circuit remodeling |
| Q34509725 | Drug-induced psychosis: how to avoid star gazing in schizophrenia research by looking at more obvious sources of light |
| Q58749186 | Dual Dopaminergic Regulation of Corticostriatal Plasticity by Cholinergic Interneurons and Indirect Pathway Medium Spiny Neurons |
| Q37415294 | Dynamic reorganization of striatal circuits during the acquisition and consolidation of a skill. |
| Q38722989 | Dysregulation of striatal projection neurons in Parkinson's disease |
| Q36916041 | Electroacupuncture inhibition of hyperalgesia in rats with adjuvant arthritis: involvement of cannabinoid receptor 1 and dopamine receptor subtypes in striatum. |
| Q37398453 | Electrophysiological Characterization of AMPA and NMDA Receptors in Rat Dorsal Striatum |
| Q41557765 | Electrophysiological Measurement of Cannabinoid-Mediated Synaptic Modulation in Acute Mouse Brain Slices |
| Q64097566 | Electrophysiological Properties of Medium Spiny Neuron Subtypes in the Caudate-Putamen of Prepubertal Male and Female -tdTomato Line 6 BAC Transgenic Mice |
| Q89428319 | Electrophysiological properties of medium spiny neurons in the nucleus accumbens core of prepubertal male and female Drd1a-tdTomato line 6 BAC transgenic mice |
| Q90369314 | Endocannabinoid LTD in Accumbal D1 Neurons Mediates Reward-Seeking Behavior |
| Q38018946 | Endocannabinoid modulation of dopaminergic motor circuits. |
| Q35679432 | Endocannabinoid signaling and long-term synaptic plasticity. |
| Q37262759 | Endocannabinoid signaling as a synaptic circuit breaker in neurological disease |
| Q39353443 | Endocannabinoid signaling mediates psychomotor activation by adenosine A2A antagonists. |
| Q39368845 | Endocannabinoid system in neurodegenerative disorders. |
| Q47570978 | Endocannabinoid-Specific Impairment in Synaptic Plasticity in Striatum of Huntington's Disease Mouse Model |
| Q35898412 | Endocannabinoid-dopamine interactions in striatal synaptic plasticity |
| Q37363621 | Endocannabinoid-mediated control of synaptic transmission |
| Q37870597 | Endocannabinoids and retrograde modulation of synaptic transmission |
| Q36686382 | Endocannabinoids in striatal plasticity |
| Q34084682 | Endocannabinoids in synaptic plasticity and neuroprotection |
| Q30762059 | Enhanced GABA Transmission Drives Bradykinesia Following Loss of Dopamine D2 Receptor Signaling. |
| Q34797508 | Ethanol affects striatal interneurons directly and projection neurons through a reduction in cholinergic tone |
| Q34413842 | Excitability decreasing central motor plasticity is retained in multiple sclerosis patients. |
| Q37422261 | Excitatory and inhibitory synapses in neuropeptide Y-expressing striatal interneurons |
| Q34351068 | Exercise-enhanced neuroplasticity targeting motor and cognitive circuitry in Parkinson's disease. |
| Q34330022 | Extrastriatal dopaminergic circuits of the Basal Ganglia |
| Q28285103 | Fatty acid amide hydrolase as a potential therapeutic target for the treatment of pain and CNS disorders |
| Q41479982 | From real-world events to psychosis: the emerging neuropharmacology of delusions |
| Q27015687 | Functional Differences Between Direct and Indirect Striatal Output Pathways in Huntington's Disease |
| Q37112496 | Functional Relevance of Different Basal Ganglia Pathways Investigated in a Spiking Model with Reward Dependent Plasticity |
| Q60917742 | Functional and behavioral consequences of Parkinson's disease-associated G2019S mutation |
| Q28589264 | Functional disturbances in the striatum by region-specific ablation of NMDA receptors |
| Q22252880 | Functional organization of the basal ganglia: Therapeutic implications for Parkinson's disease |
| Q50200300 | Functional relevance of endocannabinoid-dependent synaptic plasticity in the CNS. |
| Q48698997 | Gating the polarity of endocannabinoid-mediated synaptic plasticity by nitric oxide in the spinal locomotor network |
| Q42175447 | Gene expression analyses identify Narp contribution in the development of L-DOPA-induced dyskinesia |
| Q37170603 | Gene-environment interactions affect long-term depression (LTD) through changes in dopamine receptor affinity in Snap25 deficient mice. |
| Q46446129 | Genetic control of instrumental conditioning by striatopallidal neuron-specific S1P receptor Gpr6. |
| Q28469322 | Genetic dissection of behavioural and autonomic effects of Delta(9)-tetrahydrocannabinol in mice |
| Q24674131 | Genetic triple dissociation reveals multiple roles for dopamine in reinforcement learning |
| Q39890360 | GluN1 deletions in D1- and A2A-expressing cell types reveal distinct modes of behavioral regulation |
| Q24620534 | Group 1 mGluR-dependent synaptic long-term depression: mechanisms and implications for circuitry and disease |
| Q37036614 | Habenula: crossroad between the basal ganglia and the limbic system |
| Q37532356 | Habit Formation after Random Interval Training Is Associated with Increased Adenosine A2A Receptor and Dopamine D2 Receptor Heterodimers in the Striatum |
| Q48541253 | Haloperidol Selectively Remodels Striatal Indirect Pathway Circuits |
| Q41883668 | Heterogeneous properties of central lateral and parafascicular thalamic synapses in the striatum. |
| Q24652245 | Heteromerization of dopamine D2 receptors with dopamine D1 or D5 receptors generates intracellular calcium signaling by different mechanisms |
| Q37395798 | High on habits |
| Q34763903 | High-throughput electrophysiology: an emerging paradigm for ion-channel screening and physiology |
| Q38753843 | Hippocampal metabotropic glutamate receptor long-term depression in health and disease: focus on mitogen-activated protein kinase pathways. |
| Q53273194 | Histamine Excites Striatal Dopamine D1 and D2 Receptor-Expressing Neurons via Postsynaptic H1 and H2 Receptors. |
| Q41814232 | Histone H3 phosphorylation is under the opposite tonic control of dopamine D2 and adenosine A2A receptors in striatopallidal neurons. |
| Q33500170 | Homeostatic plasticity of striatal neurons intrinsic excitability following dopamine depletion |
| Q33999262 | Immunohistochemical localization of AMPA-type glutamate receptor subunits in the striatum of rhesus monkey |
| Q30578265 | Impaired fear memory specificity associated with deficient endocannabinoid-dependent long-term plasticity |
| Q37610892 | Implicit learning in aging: extant patterns and new directions |
| Q33751118 | In vivo pharmacology of endocannabinoids and their metabolic inhibitors: therapeutic implications in Parkinson's disease and abuse liability |
| Q91967111 | Indirect Medium Spiny Neurons in the Dorsomedial Striatum Regulate Ethanol-Containing Conditioned Reward Seeking |
| Q41852040 | Induction of cannabinoid- and N-methyl-D-aspartate receptor-mediated long-term depression in the nucleus accumbens and dorsolateral striatum is region and age dependent |
| Q28387521 | Inhibition of Phosphodiesterase 10A Increases the Responsiveness of Striatal Projection Neurons to Cortical Stimulation |
| Q39801798 | Inhibition of phosphodiesterases rescues striatal long-term depression and reduces levodopa-induced dyskinesia. |
| Q33996977 | Inhibition of striatal dopamine release by CB1 receptor activation requires nonsynaptic communication involving GABA, H2O2, and KATP channels |
| Q46059093 | Inhibitory contribution to suprathreshold corticostriatal responses: an experimental and modeling study |
| Q42268862 | Initial elevations in glutamate and dopamine neurotransmission decline with age, as does exploratory behavior, in LRRK2 G2019S knock-in mice |
| Q42470816 | Input- and cell-type-specific endocannabinoid-dependent LTD in the striatum. |
| Q24632803 | Integrated signaling in heterodimers and receptor mosaics of different types of GPCRs of the forebrain: relevance for schizophrenia |
| Q34029003 | Integrating synaptic plasticity and striatal circuit function in addiction |
| Q45218750 | Intratelencephalic corticostriatal neurons equally excite striatonigral and striatopallidal neurons and their discharge activity is selectively reduced in experimental parkinsonism |
| Q35932567 | Inversion of dopamine responses in striatal medium spiny neurons and involuntary movements |
| Q27026279 | Investigating striatal function through cell-type-specific manipulations |
| Q52655473 | Kainate Receptors Inhibit Glutamate Release Via Mobilization of Endocannabinoids in Striatal Direct Pathway Spiny Projection Neurons. |
| Q54707901 | Key modulatory role of presynaptic adenosine A2A receptors in cortical neurotransmission to the striatal direct pathway. |
| Q42467623 | LRRK2 overexpression alters glutamatergic presynaptic plasticity, striatal dopamine tone, postsynaptic signal transduction, motor activity and memory |
| Q27002626 | Levodopa-induced plasticity: a double-edged sword in Parkinson's disease? |
| Q58868609 | Long-Lasting NMDA Receptor-Mediated EPSCs in Mouse Striatal Medium Spiny Neurons |
| Q88513707 | Long-Term Plasticity of Neurotransmitter Release: Emerging Mechanisms and Contributions to Brain Function and Disease |
| Q44345217 | Long-term plasticity of corticostriatal synapses is modulated by pathway-specific co-release of opioids through κ-opioid receptors |
| Q24658338 | Looking for the role of cannabinoid receptor heteromers in striatal function |
| Q39735904 | Loss of Homeostasis in the Direct Pathway in a Mouse Model of Asymptomatic Parkinson's Disease. |
| Q36861976 | Loss of cannabinoid CB1 receptor expression in the 6-hydroxydopamine-induced nigrostriatal terminal lesion model of Parkinson's disease in the rat. |
| Q36892615 | M4 Muscarinic Receptor Signaling Ameliorates Striatal Plasticity Deficits in Models of L-DOPA-Induced Dyskinesia |
| Q37516434 | Maladaptive Synaptic Plasticity in L-DOPA-Induced Dyskinesia |
| Q37512670 | Marijuana Compounds: A Nonconventional Approach to Parkinson's Disease Therapy. |
| Q46108447 | Maturation of excitatory synaptic transmission of the rat nucleus accumbens from juvenile to adult |
| Q34613020 | Membrane properties of striatal direct and indirect pathway neurons in mouse and rat slices and their modulation by dopamine |
| Q40313187 | Metabolic, synaptic and behavioral impact of 5-week chronic deep brain stimulation in hemiparkinsonian rats. |
| Q43100078 | Metaplasticity of hypothalamic synapses following in vivo challenge |
| Q34749047 | Milestones in research on the pathophysiology of Parkinson's disease |
| Q96228741 | Modulation of dopamine D1 receptors via histamine H3 receptors is a novel therapeutic target for Huntington's disease |
| Q36367283 | Modulation of striatal projection systems by dopamine |
| Q26830654 | Modulation of the glutamatergic transmission by Dopamine: a focus on Parkinson, Huntington and Addiction diseases |
| Q50069504 | Molecular insights into cortico-striatal miscommunications in Huntington's disease |
| Q37629974 | Molecular profiling of striatonigral and striatopallidal medium spiny neurons past, present, and future |
| Q47569238 | Motor learning and metaplasticity in striatal neurons: relevance for Parkinson's disease |
| Q38739709 | Motor learning in animal models of Parkinson's disease: Aberrant synaptic plasticity in the motor cortex |
| Q36940345 | Multiple sources of striatal inhibition are differentially affected in Huntington's disease mouse models |
| Q42481097 | NEUROSCIENCE. Astrocytes tell neurons when to listen up. |
| Q37132571 | Neurochemical changes in the striatum of dyskinetic rats after administration of the cannabinoid agonist WIN55,212-2 |
| Q37308026 | Neurocomputational models of basal ganglia function in learning, memory and choice |
| Q37778902 | Neurocomputational models of motor and cognitive deficits in Parkinson's disease |
| Q37844744 | Neuromodulatory control of striatal plasticity and behavior. |
| Q22241960 | Neuronal Reward and Decision Signals: From Theories to Data |
| Q47326858 | Neuroprotective activity of cannabinoid receptor-2 against oxidative stress and apoptosis in rat pups having experimentally-induced congenital hypothyroidism. |
| Q37680104 | Neurotransmitter roles in synaptic modulation, plasticity and learning in the dorsal striatum |
| Q36074595 | New insights on endocannabinoid transmission in psychomotor disorders |
| Q38038559 | New synaptic and molecular targets for neuroprotection in Parkinson's disease |
| Q42789671 | Nicotinic acetylcholine receptor density in cognitively intact subjects at an early stage of Parkinson's disease. |
| Q41809772 | Nigrostriatal denervation changes the effect of cannabinoids on subthalamic neuronal activity in rats. |
| Q42785592 | Nitric Oxide-Soluble Guanylyl Cyclase-Cyclic GMP Signaling in the Striatum: New Targets for the Treatment of Parkinson's Disease? |
| Q36914301 | Npas1+ Pallidal Neurons Target Striatal Projection Neurons |
| Q90196706 | Nuclear Receptor Nr4a1 Regulates Striatal Striosome Development and Dopamine D1 Receptor Signaling |
| Q46570512 | Opposing patterns of signaling activation in dopamine D1 and D2 receptor-expressing striatal neurons in response to cocaine and haloperidol |
| Q41791746 | Opposing roles of synaptic and extrasynaptic NMDA receptor signaling in cocultured striatal and cortical neurons |
| Q35575588 | Opposite function of dopamine D1 and N-methyl-D-aspartate receptors in striatal cannabinoid-mediated signaling |
| Q91790352 | Origins of Parkinson's Disease in Brain Development: Insights From Early and Persistent Effects of LRRK2-G2019S on Striatal Circuits |
| Q33955359 | Overexpression of SIRT1 in mouse forebrain impairs lipid/glucose metabolism and motor function. |
| Q33714587 | Oxidation of the endogenous cannabinoid arachidonoyl ethanolamide by the cytochrome P450 monooxygenases: physiological and pharmacological implications |
| Q55255522 | Oxytocin functions as a spatiotemporal filter for excitatory synaptic inputs to VTA dopamine neurons. |
| Q41866674 | P2Y1 receptor modulation of Ca2+-activated K+ currents in medium-sized neurons from neonatal rat striatal slices |
| Q37705771 | Parental THC exposure leads to compulsive heroin-seeking and altered striatal synaptic plasticity in the subsequent generation. |
| Q64911660 | Parkinson's Disease-Linked LRRK2-G2019S Mutation Alters Synaptic Plasticity and Promotes Resilience to Chronic Social Stress in Young Adulthood. |
| Q37930190 | Pathophysiology of Huntington's disease: time-dependent alterations in synaptic and receptor function. |
| Q44342408 | Pathway- and Cell-Specific Kappa-Opioid Receptor Modulation of Excitation-Inhibition Balance Differentially Gates D1 and D2 Accumbens Neuron Activity |
| Q50092568 | Pathway-Specific Control of Striatal Neuron Vulnerability by Corticostriatal Cannabinoid CB1 Receptors. |
| Q36512106 | Pathway-specific modulation of nucleus accumbens in reward and aversive behavior via selective transmitter receptors |
| Q94599920 | Perinatal interference with the serotonergic system affects VTA function in the adult via glutamate co-transmission |
| Q55111952 | Pharmacological Blockade of Adenosine A2A but Not A1 Receptors Enhances Goal-Directed Valuation in Satiety-Based Instrumental Behavior. |
| Q35166968 | Pharmacological evidence for different populations of postsynaptic adenosine A2A receptors in the rat striatum |
| Q36031693 | Phenotype-dependent inhibition of glutamatergic transmission on nucleus accumbens medium spiny neurons by the abused inhalant toluene |
| Q43704187 | Plasticity of hypothalamic dopamine neurons during lactation results in dissociation of electrical activity and release. |
| Q27011417 | Possible involvement of self-defense mechanisms in the preferential vulnerability of the striatum in Huntington's disease |
| Q30500199 | Postsynaptic TRPV1 triggers cell type–specific long-term depression in the nucleus accumbens |
| Q42509576 | Predicting the response of striatal spiny neurons to sinusoidal input. |
| Q34390849 | Prenatal ethanol exposure alters synaptic plasticity in the dorsolateral striatum of rat offspring via changing the reactivity of dopamine receptor |
| Q26853387 | Preservation of function in Parkinson's disease: what's learning got to do with it? |
| Q35762827 | Presynaptic LTP and LTD of excitatory and inhibitory synapses |
| Q35039222 | Presynaptic adenosine A2A receptors dampen cannabinoid CB1 receptor-mediated inhibition of corticostriatal glutamatergic transmission |
| Q38557880 | Probing striatal microcircuitry to understand the functional role of cholinergic interneurons |
| Q35499568 | Promising cannabinoid-based therapies for Parkinson's disease: motor symptoms to neuroprotection |
| Q60949363 | Proteomic Profile of Carbonylated Proteins Screen Regulation of Apoptosis via CaMK Signaling in Response to Regular Aerobic Exercise |
| Q92885571 | RETRACTED ARTICLE: Amelioration of obsessive-compulsive disorder in three mouse models treated with one epigenetic drug: unraveling the underlying mechanism |
| Q30504550 | RGS4 is required for dopaminergic control of striatal LTD and susceptibility to parkinsonian motor deficits |
| Q38366676 | Rapid target-specific remodeling of fast-spiking inhibitory circuits after loss of dopamine. |
| Q39732881 | Recurrent collateral connections of striatal medium spiny neurons are disrupted in models of Parkinson's disease |
| Q34961512 | Regulation of dendritic calcium release in striatal spiny projection neurons |
| Q24630976 | Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry |
| Q36754113 | Regulator of calmodulin signaling knockout mice display anxiety-like behavior and motivational deficits |
| Q41518121 | Reinforcement determines the timing dependence of corticostriatal synaptic plasticity in vivo |
| Q33362024 | Retinoic Acid Signaling: A New Piece in the Spoken Language Puzzle |
| Q30497841 | Reversing cocaine-induced synaptic potentiation provides enduring protection from relapse. |
| Q28394979 | Review: Modulation of striatal neuron activity by cyclic nucleotide signaling and phosphodiesterase inhibition |
| Q49834838 | Role of Striatal Direct Pathway 2-Arachidonoylglycerol Signaling in Sociability and Repetitive Behavior |
| Q39190510 | Roles of centromedian parafascicular nuclei of thalamus and cholinergic interneurons in the dorsal striatum in associative learning of environmental events |
| Q48720514 | SK channel modulation rescues striatal plasticity and control over habit in cannabinoid tolerance |
| Q36008922 | Sapap3 deletion anomalously activates short-term endocannabinoid-mediated synaptic plasticity |
| Q35075199 | Selective inactivation of adenosine A(2A) receptors in striatal neurons enhances working memory and reversal learning. |
| Q36535361 | Selective presynaptic enhancement of the prefrontal cortex to nucleus accumbens pathway by cocaine. |
| Q35040674 | Serotonin induces long-term depression at corticostriatal synapses |
| Q34560043 | Short latency cerebellar modulation of the basal ganglia |
| Q34554544 | Single dose of a dopamine agonist impairs reinforcement learning in humans: evidence from event-related potentials and computational modeling of striatal-cortical function |
| Q28707279 | Speech-induced striatal dopamine release is left lateralized and coupled to functional striatal circuits in healthy humans: a combined PET, fMRI and DTI study |
| Q64086843 | Spiny Projection Neuron Dynamics in Toxin and Transgenic Models of Parkinson's Disease |
| Q36288401 | Strain-specific regulation of striatal phenotype in Drd2-eGFP BAC transgenic mice |
| Q42099006 | Striatal D2 receptors regulate dendritic morphology of medium spiny neurons via Kir2 channels. |
| Q37925513 | Striatal Signaling in L-DOPA-Induced Dyskinesia: Common Mechanisms with Drug Abuse and Long Term Memory Involving D1 Dopamine Receptor Stimulation. |
| Q39414543 | Striatal cholinergic interneurons and Parkinson's disease. |
| Q38271951 | Striatal direct and indirect pathways control decision-making behavior. |
| Q21143854 | Striatal medium-sized spiny neurons: identification by nuclear staining and study of neuronal subpopulations in BAC transgenic mice |
| Q37336143 | Striatal plasticity and basal ganglia circuit function |
| Q36763909 | Striatal plasticity and medium spiny neuron dendritic remodeling in parkinsonism |
| Q48138673 | Striatal synapses, circuits, and Parkinson's disease |
| Q40936456 | Striatopallidal Neuron NMDA Receptors Control Synaptic Connectivity, Locomotor, and Goal-Directed Behaviors |
| Q30008746 | Striatopallidal dysfunction underlies repetitive behavior in Shank3-deficient model of autism |
| Q64866431 | Structure-Activity Relationship of Cannabis Derived Compounds for the Treatment of Neuronal Activity-Related Diseases |
| Q37346328 | Supersensitive presynaptic dopamine D2 receptor inhibition of the striatopallidal projection in nigrostriatal dopamine-deficient mice |
| Q39381131 | Synaptic functions of endocannabinoid signaling in health and disease |
| Q22337221 | Synaptic plasticity and addiction |
| Q37702356 | Synaptic plasticity in the mesolimbic system: therapeutic implications for substance abuse |
| Q28242702 | Synaptic plasticity: multiple forms, functions, and mechanisms |
| Q37578353 | Synchronized firing of fast-spiking interneurons is critical to maintain balanced firing between direct and indirect pathway neurons of the striatum |
| Q37098652 | Synthesis and quantitative structure-activity relationship of fatty acid amide hydrolase inhibitors: modulation at the N-portion of biphenyl-3-yl alkylcarbamates. |
| Q37031746 | Target-cell-dependent plasticity within the mossy fibre-CA3 circuit reveals compartmentalized regulation of presynaptic function at divergent release sites |
| Q30474602 | Targeting neuronal populations of the striatum |
| Q90053610 | Targeting the cholinergic system in Parkinson's disease |
| Q37150745 | Targeting the endocannabinoid system: to enhance or reduce? |
| Q60715991 | The Distinct Role of Medium Spiny Neurons and Cholinergic Interneurons in the D2/A2A Receptor Interaction in the Striatum: Implications for Parkinson's Disease |
| Q30498111 | The Drosophila miR-310 cluster negatively regulates synaptic strength at the neuromuscular junction |
| Q36943239 | The FAAH inhibitor URB597 efficiently reduces tyrosine hydroxylase expression through CB₁- and FAAH-independent mechanisms |
| Q92957609 | The Projection Targets of Medium Spiny Neurons Govern Cocaine-Evoked Synaptic Plasticity in the Nucleus Accumbens |
| Q61804251 | The Role of Lipids in Parkinson's Disease |
| Q55427881 | The adjustment of γ-aminobutyric acidA tonic subunits in Huntington's disease: from transcription to translation to synaptic levels into the neostriatum. |
| Q53076152 | The antipsychotic landscape: dopamine and beyond. |
| Q42495608 | The bright side of psychoactive substances: cannabinoid-based drugs in motor diseases. |
| Q35740152 | The cannabinoid agonist WIN55212-2 decreases L-DOPA-induced PKA activation and dyskinetic behavior in 6-OHDA-treated rats |
| Q34267133 | The decrease of dopamine D₂/D₃ receptor densities in the putamen and nucleus caudatus goes parallel with maintained levels of CB₁ cannabinoid receptors in Parkinson's disease: a preliminary autoradiographic study with the selective dopamine D₂/D₃ an |
| Q36630516 | The endocannabinoid 2-arachidonoylglycerol mediates D1 and D2 receptor cooperative enhancement of rat nucleus accumbens core neuron firing |
| Q37394164 | The endocannabinoid system as a target for the treatment of motor dysfunction |
| Q34098196 | The endocannabinoid system as a target for the treatment of neurodegenerative disease |
| Q28264155 | The ins and outs of the striatum: role in drug addiction |
| Q34660573 | The major central endocannabinoid directly acts at GABA(A) receptors |
| Q88150069 | The missing, the short, and the long: Levodopa responses and dopamine actions |
| Q45923772 | The pharmacological blockade of medial forebrain bundle induces an acute pathological synchronization of the cortico-subthalamic nucleus-globus pallidus pathway. |
| Q40663529 | The role of dopamine in modulating the structure and function of striatal circuits. |
| Q33687660 | The role of dopamine in risk taking: a specific look at Parkinson's disease and gambling |
| Q38099197 | The role of neuroplasticity in dopaminergic therapy for Parkinson disease. |
| Q30499665 | The small-conductance calcium-activated potassium channel is a key modulator of firing and long-term depression in the dorsal striatum |
| Q37910746 | The striatal balancing act in drug addiction: distinct roles of direct and indirect pathway medium spiny neurons |
| Q35171113 | The therapeutic potential of cannabinoids for movement disorders |
| Q37402927 | The therapeutic potential of novel cannabinoid receptors |
| Q36957968 | Therapeutic potential of endocannabinoid-hydrolysing enzyme inhibitors. |
| Q58090420 | Thinking Outside the Box (and Arrow): Current Themes in Striatal Dysfunction in Movement Disorders |
| Q47838280 | Timing and location of synaptic inputs determine modes of subthreshold integration in striatal medium spiny neurons. |
| Q49169649 | Tonically Active α2 Subunit-Containing Glycine Receptors Regulate the Excitability of Striatal Medium Spiny Neurons |
| Q48873079 | Toward a model of retrograde regulation of striatal synaptic depression. |
| Q48355383 | URB597 and the Cannabinoid WIN55,212-2 Reduce Behavioral and Neurochemical Deficits Induced by MPTP in Mice: Possible Role of Redox Modulation and NMDA Receptors |
| Q41431345 | Untangling Basal Ganglia Network Dynamics and Function: Role of Dopamine Depletion and Inhibition Investigated in a Spiking Network Model |
| Q37400352 | Updating dopamine reward signals |
| Q37687946 | Utility of genetically modified mice for understanding the neurobiology of substance use disorders |
| Q37371387 | WIN55,212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease. |
| Q38153344 | What can we learn about schizophrenia from studying the human model, drug-induced psychosis? |
| Q34201532 | What is the degree of segregation between striatonigral and striatopallidal projections? |
| Q35574934 | Zooming in on the small: the plasticity of striatal dendritic spines in L-DOPA-induced dyskinesia |
| Q33771857 | mGluR-mediated and endocannabinoid-dependent long-term depression in the hilar region of the rat dentate gyrus |